T1	Participants 37 75	patients with chronic myeloid leukemia
T2	Participants 233 271	patients with chronic myeloid leukemia
T3	Participants 566 731	Fifty-seven patients were randomized to receive 2.0 Gy fractions of irradiation daily for 6 days and 59 were randomized to receive 2.25 Gy fractions daily for 7 days
